MaxRev Coming Soon
MaxRev — Price Every Unit, Your Way.
Launching soon
Revenue Management for Self-Storage

MaxRev is coming soon.

We’re putting the finishing touches on Revenue Management software built for Self-Storage operators, from a single Facility to a full Portfolio. You set the Pricing Model. MaxRev helps you set every Rate, Unit by Unit.

5×5Locker
5×10Small
10×10Medium
10×15Medium
10×20Large
10×30Extra large

A first look at what’s coming

Built from what Self-Storage operators told us they need, and nothing they didn’t.

Strategy

Choose your Pricing Model

Pick one of three Pricing Models to match how you run your Facility, plus a New Facility Lease-Up mode for properties still filling up.

Daily

Rate Watch

A short daily review of the Rates that changed and the Units that need your attention, so you stay in control without living in a spreadsheet.

Transparency

See the reasoning

The Trace view shows how each suggested Rate was reached. Every recommendation is explained, and every decision stays yours.

Get an early walkthrough

See MaxRev before launch and tell us what your Facilities need. We’ll show you the product and answer your questions.

Book a Demo
MaxRev is a product of Apoorva Corporation · Broomfield, Colorado Questions? support@apoorva.com © 2026 Apoorva Corporation

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.